CX NEWS
News from CX 2019: Evidence supports safety of paclitaxel-coated devices
At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco, USA) and Eric Secemsky (Boston, USA). The panel outlines the [...]
Podium 1st: The impact of polymer sealing on neck-related adverse events: Five-year results from ENCORE
Recorded presentation from CX Symposium 2019 Hence Verhagen, Rotterdam, Netherlands
Podium 1st: New developments in fusion imaging – artificial intelligence that deforms anatomy to maintain accuracy
Recorded presentation from CX Symposium 2019 Bijan Modarai, London, United Kingdom
Podium 1st: Potential EVAS cardiovascular mortality benefit through active sac management when compared to EVAR
Recorded presentation from CX Symposium 2019 Marc Schermerhorn, Boston, United States
Breaking news from CX 2019: Cook leads the way to data transparency with release of long-term ZILVER PTX patient-level data
There were several calls at the CX 2019 Highlight Session Paclitaxel: The last word on the need for a meta-analysis of individual patient-level data going forward and greater transparency and sharing of the available [...]
Key take-aways from the CX 2019 Highlight Session on Paclitaxel: The Last Word
Elena Ladich (Hollywood, USA) and Roger Greenhalgh (London, UK) discuss the current uncertainty surrounding the use of paclitaxel devices and the need for individual patient-level data analyses going forward to better understand the mortality [...]